<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=euc-jp" />
<meta http-equiv="content-style-type" content="text/css" />
<meta http-equiv="content-script-type" content="text/javascript" />

<title>Past Issues | YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;</title>

<meta name="Description" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta name="Keywords" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta http-equiv="imagetoolbar" content="no" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/style.css" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/en.css" />
<script type="text/javascript" src="../../js/jquery.js"></script>
<script type="text/javascript" src="../../js/jquery.function.js"></script>
</head>

<body class="page">
<div id="container">

<div id="header">
<p id="siteLogo"><a href="../../en.html"><img src="../../img/common/logo_en.gif" alt="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" width="437" height="28" /></a></p>
<p id="tagline"> YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; is the private medical supply supervisory system.</p>
<div id="navUtility">
<ul>
<li><a href="../sitemap.html">Sitemap</a></li>
<li><a href="../../index.html">Japanese</a></li>
</ul>
<!-- /#navUtility --></div>
<div id="searchArea">
<form name="form1" action="http://www.yakugai.gr.jp/en/search.php" method="post">
<p><input id="searchInput" name="keyword" type="text" />&nbsp;<input value="Search" type="submit" /></p>
</form>
<!-- /#searchInput --></div>
<!-- /#header --></div>

<div id="nav">
<ul>
<li id="navHome"><a href="../../en.html">Home</a></li>
<li><a href="../about.html">About Us</a></li>
<li><a href="../activity.html">Activities</a></li>
<li class="current"><a href="../inve.html">Past Issues</a></li>
<li><a href="../about/about_links.html">Links</a></li>
</ul>
<!-- /#nav --></div>

<div class="inve" id="pageTitle">
<h1>Past Issues</h1>
<!-- /#pageTitle --></div>

<div id="topicPath">
<ol>
<li id="topicPathHome"><a href="../../en.html">Home</a></li>
<li>Past Issues</li>
</ol>
<!-- /#topicPath --></div>

<div id="contents">
<div id="main">
<h2>Tamiflu (oseltamivir phosphate)</h2>

<div id="inveArticle"><p>
 <br />
Tamiflul (Capsule 75  and Dry syrup뫎was approved in 2001 and 2002 respectively, as an antiviral drug for treatment of influenza type A and B and their prophylaxis.<br />
<br />
Proved efficacy is that duration of influenza-fever is shortened only by one day.<br />
On the other hand, soon after coming on the market, adverse events such as disturbance of consciousness, abnormal behaviour and sudden death have been reported.<br />
<br />
Seventy per-cent of worldwide sales were in Japan during Jan-Mar in 2003.<br />
Pandemic preparedness by the Japanese government has spent 52.9 billion yen for drug stockpiles from 2006 to 2007.<br />
<br />
뫋Study on the development of symptoms with influenza뫌 funded by The Ministry of Health, Labour and Welfare (the MHLW),  in which events with  Tamiful usage would be analyzed, was carried out in 2008. <br />
However, the interim report of outcomes included incorrect implication and treatment of the data. The final report of the study on Apr 19,2009 was that the association of Tamiful with abnormal behaviours could not be모denied.<br />
<br />
<br />
Our activities are as follows몮<br />
<br />
2005-11-11<br />
Campaign to enlighten the public on the website:뫌Do you take Tamiful despite the risks ?뫌<br />
<br />
2006- 2- 5<br />
Held a symposium coordinated with Tie-Up Group: 뫋You may make a big mistake for measures against influenza. Neither Vaccine nor Tamiful protect you! 뫌<br />
<br />
2006- 3- 6<br />
Held the lecture at the 7 th Anniversary of Sapporo Tie-Up Group, entitled as the same as the symposium above.<br />
<br />
2007- 3-19<br />
Submission of a written letter entitled 뫋Open question and request about Tamiful뫌 to demand the urgent issue of safety information to the MHLW. <br />
Submission of a written letter entitled 뫋Conflict of interest regarding Tamiful뫌 to demand the exclusion of persons with financial relationship with Roche and Chugai Pharma from the members of the MHLW-funded모study.<br />
(During the winter season in 2007, several incidents were reported in young students after use of Tamiful.)<br />
<br />
2007- 3-23<br />
Submission of a written request to the MHLW, entitled 뫋Prohibit the use of Tamiful for all ages and open all of the information regarding adverse events to the public뫌, against the urgent issue by the MHLW that Tamiful should not be used as a general rule for children younger than ten years old, on Mar 20 2007.<br />
<br />
2007- 4- 2<br />
Preparation of the revised version:뫌Do you take Tamiful despite the risks?뫌<br />
<br />
2007- 4-12<br />
The secretary general of Medwatcher Japan   made a statement about our request at the task force for safety measures held at the MHLW.<br />
<br />
2007-12-13<br />
Submission of a written request to the MHLW, entitled 뫋Procedure to investigate Tamiful usage at the task force for safety measures뫌<br />
<br />
2007-12-14<br />
Released on our website a poster for healthcare professionals: 뫋Tamiful뫌<br />
<br />
2007-12-26<br />
Released on our website a visual poster for education: 뫋Influenza and Tamiful뫌   <br />
<br />
2008- 9-12<br />
Submission of a written request to the MHLW, entitled 뫋Action to prohibit the use of Tamiful뫌, against the incorrect analysis of 뫋Study on the development of symptoms with influenza뫌 on Jul 10 2008.<br />
<br />
2008-12-24<br />
Submission of a written request to the MHLW, entitled 뫋Open the basic data regarding the Study on the development of symptoms with influenza to the public뫌. <br />
<!-- /#inveArticle --></p></div>

<div class="sectionList" >
<h3>Topics</h3>
<ul class="ex">
<li class="person">YAKUGAI Ombudsperson</li>
<li class="tieup">Tie-up Group</li>
</ul>
<p>No Related Information</p><!-- /.sectionList -->
</div>
<!-- /#main --></div>

<div id="sub">
<h2>Table Of Contents</h2>
<div id="navSub">
<ul>
<li><a href="index.php.html#inveDrug">Drugs</a></li>
<li><a href="index.php.html#inveSystem">Systems</a></li>
</ul>
<!-- /#navSub --></div>
<!-- /#sub --></div>
<!-- /#contents --></div>

<div id="footer">
<p id="siteAdress">YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; Tie-up group<br />
160-0022모Tokyo Shinjuku Ward Shinjuku 1-14-4  AM building<br />
TEL : 03뫍3350뫎0607모FAX : 03뫍5363뫎7080<br />
Mail : <a href="mailto:info@yakugai.gr.jp">&#105;&#110;&#102;o&#64;y&#97;&#107;u&#103;&#97;&#105;&#46;&#103;r.&#106;&#112;</a></p>

<div id="footerInner">
<ul id="navFooter">
<li><a href="../privacy.html">Privacy Policy</a></li>
</ul>
<p id="siteInfo">Our members have other regular jobs and volunteer their services free of charge. Our secretariat also serves as part-time basis, and we are currently in the process of facilitating the secretariat function. Therefore, please note that due to limited resources, we might not be able to respond to each inquiry on specific medicine. Thank you for your understanding.</p>
<p id="copyright"><img src="../../img/common/copyright.gif" alt="Copyright (c) YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;. all rights reserved." width="419" height="11" /></p>
<!-- /#footerInner --></div>

<!-- /#footer --></div>

<!-- /#container --></div>

<!-- google Analytics -->
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-11615542-1");
pageTracker._trackPageview();
} catch(err) {}
</script>
<!-- /google Analytics -->
<!-- nakanohito -->
<script LANGUAGE="Javascript">
<!--
var refer = document.referrer;
document.write("<a href='http://nakanohito.jp/'>");
document.write("<img src='http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=&version=js&refer="+escape(parent.document.referrer)+"&url="+escape(parent.document.URL)+"' border='0' width='48' height='48' />");
document.write("</a>");
//-->
</script>
<noscript>
<img src="http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=" width="48" height="48" alt="" border="0" />
</noscript>
<!-- nakanohito end -->

</body>
</html>
